Overview
Yoshihiko Kunisato practices practicing medicine in Kawasaki, Japan.
His clinical expertise encompasses COVID-19 and Attention Deficit Hyperactivity Disorder (ADHD).
He is actively involved in clinical research, co-authoring 41 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yoshihiko Kunisato
Is Yoshihiko Kunisato a top-rated expert for COVID-19?
MediFind is an objective health platform that identifies experts based on real-world data. Yoshihiko Kunisato is classified as an Experienced expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yoshihiko Kunisato participate in research or clinical trials?
Yes. Yoshihiko Kunisato has published 41 articles and abstracts on conditions like COVID-19. You can view a list of Yoshihiko Kunisato's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Attention Deficit Hyperactivity Disorder (ADHD)
- COVID-19Mr. Kunisato isExperienced. Learn about COVID-19.